Get more info

Get more information
on LUCENTIS:
1-866-LUCENTIS
(1-866-582-3684)

Monday-Friday
8AM-9PM (EST)

 

   

Helpful features found on this site

We understand that living with low vision can be difficult. And we want you to get the most out of our Web site. That’s why we’ve added features to the site that help make it easier to access.

Change the text size
This feature gives you the ability to increase or decrease the size of the text found on this site. To make it easier for you to read, you can make the text bigger. You can also make the text smaller if necessary.

View this site as text only
You can view this site with or without graphics or pictures. If it's difficult for you to read each page, you may be interested in the "text-only version" of this site.

Graphics Version
This version allows you to see all the images and callouts that are associated with each page's core content.

Text-Only Version
This version allows you to see each page's core content only. There are no images or graphic content on the page.

Hear This Page feature
This feature gives you the ability to listen to specific pages. That means that you will be able to hear about wet AMD.

For an example of the audio feature, visit the What is AMD? page.

HOW TO USE THIS FEATURE:

audio controller

Click Hear This Page to start listening to a page.

audio controller

Pause button: This allows you to take a break in what you're listening to.

Stop button: This allows you to completely stop what you're listening to. If you press "play" then you will return to the beginning of the page.




Who is LUCENTIS for?


LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).


Important LUCENTIS Safety Information


Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.


Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.


Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.


Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.


The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.


LUCENTIS is for prescription use only.

Individual results with LUCENTIS may vary.


Please see LUCENTIS full Prescribing Information.